Administration of chenodeoxycholic acid for reduction of adipose tissue may preferably be done orally, but it Will be readily apparent to those skilled in the art that other routes of administration can be used, such as trans dermally. An effective daily dosage of chenodeoxycholic acid is about 25 to 500 mg, with 100-200 mg. being most preferred. Most preferably CDCA is provided as a soft gelatin capsule or oral liquid in tWo to three divided doses per day. The method of reduction of adipose tissue disclosed herein is a significance cant improvement over existing methods, as it has better eficacy than appetite suppressants and cortisol blockers, and does not have the negative side effects associated with the use of stimulants.

For administration the active ingredient chenodeoxycholic acid thereof can be mixed with liquid carriers. It may also be delivered With a solid or semisolid carrier.CDCA may also be administered transdermally using aliquid carrier. CDCA may be delivered as in the form of an ester, ether or salt of chenodeoxycholic acid.

The amount of the active ingredient to be administered depends on various factors such as the age and weight of the user. Effective daily doses of chenodeoxycholic acid may range from 25 to 500 mg, more particularly 50 to 200 mg per day, and most preferably 100 to 200 mg per day. The dosage might be provided as a soft gelatincapsule or oral liquid. CDCA may be administered in two to three divided doses per day. Chenodeoxycholic acid may also be mixed With other weight reducing pharmaceuticals or dietary supplements such as caffeine, synephrine, or ephedrine if desired.

EXAMPLE 1

5 kg chenodeoxycholic acid Were mixed with methylcellulose, highly dispersed silicon dioxide and magnesium stearate, and placed into 100,000 hard-gelatin capsules each with a content of 50 mg chenodeoxycholic acid.

EXAMPLE 2

5 kg chenodeoxycholic acid Were mixed With 10 kg caffeine, methylcellulose, highly dispersed silicon dioxide and magnesium stearate, and placed into 100,000 hard gelatin capsules each With a content of 50 mg chenodeoxy.

From the foregoing disclosure and detailed description of certain preferred embodiments, it will be apparent that various modifcations, additions and other alternative embodiments are possible without departing from the true scope and spirit of the invention. The embody ments discussed were chosen and described to provide the best illustration of the principles of the invention and its practical application to thereby enable one of ordinary skill in the art to use the invention in various embodiments and with various modifcations as are suited to the particular use contemplated. All such modifcations and variations are within the scope of the invention as determined by the appended claims When interpreted in accordance with the breadth to Which they are fairly, legally, and equitably entitled.